Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
EDEM1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ADA - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLX1A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GARS - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CUL4A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GATAD1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
ADCK2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DUSP22 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC39A13 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
QSER1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ARHGAP18 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IREB2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
UBE2H - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC38A2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NREP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RFX7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ACP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on